Characterization of Complex Drug Products: Can we keep up with complexity?
AAPS Blog,
By: Jon S.B. de Vlieger, Daan J.A. Crommelin, and Vinod Shah Biologics and non-biological …Continue reading →
Non-Biological Complex Drugs
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Introduction: Defining the Position of Non-Biological Complex Drugs
-
Altmetric BadgeChapter 2 Polymeric Micelles
-
Altmetric BadgeChapter 3 Liposomes: The Science and the Regulatory Landscape
-
Altmetric BadgeChapter 4 Glatiramoids
-
Altmetric BadgeChapter 5 Iron Carbohydrate Complexes: Characteristics and Regulatory Challenges
-
Altmetric BadgeChapter 6 Drug Nanocrystals
-
Altmetric BadgeChapter 7 Analytical Methods for Determining the Size (Distribution) in Parenteral Dispersions
-
Altmetric BadgeChapter 8 NBCD Pharmacokinetics and Bioanalytical Methods to Measure Drug Release
-
Altmetric BadgeChapter 9 Low Molecular Weight Heparins, Biological Drugs close to Non-Biological Complex Drugs
-
Altmetric BadgeChapter 10 Nanoparticle Albumin-Bound Anticancer Agents
-
Altmetric BadgeChapter 11 The EU Regulatory Landscape of Non-Biological Complex Drugs
-
Altmetric BadgeChapter 12 Epilogue: What Did We Learn? What Can We Expect in the Future? Concluding Remarks and Outstanding Issues
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (76th percentile)
Citations
- dimensions_citation
- 32 Dimensions
Readers on
- mendeley
- 12 Mendeley